AcroMetrix LLC, headquartered in the United States, is a leading provider of innovative quality control solutions within the biotechnology and diagnostics industry. Founded in 2005, the company has established itself as a key player in the development of molecular diagnostic controls and proficiency testing products, catering to laboratories and healthcare providers across North America and beyond. AcroMetrix's core offerings include a range of unique, high-quality control materials designed to enhance the accuracy and reliability of diagnostic testing. Their commitment to scientific excellence and customer satisfaction has earned them a strong market position, recognised for their contributions to improving laboratory performance and patient outcomes. With a focus on continuous innovation, AcroMetrix remains dedicated to advancing the standards of quality in the diagnostics field.
How does AcroMetrix LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
AcroMetrix LLC's score of 94 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AcroMetrix LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Thermo Fisher Scientific Inc., which influences its climate commitments and emissions reporting. As part of its corporate family, AcroMetrix LLC adheres to the sustainability initiatives and targets set by Thermo Fisher Scientific Inc. This includes participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are aimed at reducing greenhouse gas emissions in line with climate science. However, specific reduction targets or achievements for AcroMetrix LLC have not been disclosed. While no absolute emissions figures are provided, AcroMetrix LLC's climate commitments are aligned with the broader goals of its parent company, Thermo Fisher Scientific Inc., which is actively working towards significant emissions reductions across its operations. The absence of specific data highlights the need for ongoing transparency and accountability in corporate climate strategies.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
AcroMetrix LLC's Scope 3 emissions, which decreased by 13% last year and decreased by approximately 15% since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AcroMetrix LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.